Bridgeway Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bridgeway Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-27,500	Closed	-$1.3M	–	1391
2019 Q4	$1.3M	Hold	27,500	–	–	0.02%	678
2019 Q3	$178K	Hold	27,500	–	–	﹤0.01%	1200
2019 Q2	$338K	Hold	27,500	–	–	﹤0.01%	1074
2019 Q1	$373K	Buy	+27,500	New	+$246K	﹤0.01%	1106

Other funds holding CNST

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

ROTUOC

Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return

Bridgeway Capital Management's CNST Position: Q1 2020 in Review

Bridgeway Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q1 2020, closing a stake of 27,500 shares — an estimated $1.3M sold.

Bridgeway Capital Management first reported a position in CNST in Q1 2019 and held it in 4 quarters. The position peaked at $1.3M in Q4 2019. 99 funds tracked by Wall St. Rank hold CNST as of Q1 2020.

Bridgeway Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Bridgeway Capital Management sold 27,500 Constellation Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.3M.
Bridgeway Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2019 and held it in 4 quarters.
Bridgeway Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $1.3M in Q4 2019.
99 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q1 2020.

Based on Bridgeway Capital Management's 13F filing for Q1 2020, filed 15 May 2020.